Poxviruses

Poxviruses

Biodefense Headlines – 27 April 2025

News Scan April 27, 2025

This week’s topics include a consensus on the Pandemic Treaty, a Marburg vaccine Phase II trial, legislation to increase stockpile readiness for anthrax bioterrorism, and the EU updating its medical…

Smallpox Vaccine Performs Well in Two Pivotal Studies

Misconceptions About Smallpox’s Role in Native Depopulation

Smallpox Vaccine Virus Helps UNL Scientist Understand Immunity

PharmAthene Awarded $195M+ in SIGA Smallpox Lawsuit

BAA – U.S. Army Extramural Medical Research

Emergent BioSolutions Awarded 19M for Smallpox Drug

Transcript of CDC Press Conference on Biosafety Incidents

Smallpox Vials Discovered in NIH Storage Room

Scientists Again Call for Delay in Destruction of Last Stocks of Smallpox

Children Conceived During Epidemic Have More Lifetime Resistance

BARDA Moves Forward on Freeze-Dried Smallpox Vaccine

Bavarian Nordic to Develop Biodefense Vaccine

Emergent Expands Biodefense Holdings with Acquisition of Cangene

Bavarian Nordic Completes Smallpox Vaccine Delivery to SNS

Navy Seeks CBRE Mail Screening Equipment

The Evolving Nature of Synthetic Biology: A Panel Discussion on Key Science, Policy, and Societal Challenges Facing the International Community

PharmAthene and Theraclone Sciences Announce Merger Agreement

SIGA Makes Third Delivery of Smallpox Drug for Biodefense Stockpile

NHRC, Mayo Clinic Study Immune Response Following Smallpox Vaccination

SIGA Begins Smallpox Drug Shipments to National Stockpile

Biodefense Headlines – 27 April 2025